Completed OBSERVATIONAL NCT01171404

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge (EPICOR)

Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients

Sponsor: AstraZeneca

Conditions ACS Acute Coronary Syndrome Coronary Artery Disease Myocardial Infarction Unstable Angina

Updated 7 times since 2017 Last updated: Apr 16, 2013 Started: Sep 30, 2010 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates ACS and Acute Coronary Syndrome and is currently completed. AstraZeneca leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

(Jette) Bruxelles, Belgium , Aalborg, Denmark , Aalst, Belgium , Aarhus, Denmark , Adana, Turkey (Türkiye) , Airdrie, United Kingdom , Alba Iulia, Romania , Alcalá de Henares, Spain , Alcoy, Spain , Alicante, Spain and 400 more locations